Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017;3(6):315-320.
doi: 10.1007/s40495-017-0109-y. Epub 2017 Oct 5.

Infection: a Cause of and Cure for Cancer

Affiliations
Review

Infection: a Cause of and Cure for Cancer

Jenna H Newman et al. Curr Pharmacol Rep. 2017.

Abstract

Purpose of review: This article provides a brief overview of the role that infections play in cancer emergence and cancer treatment.

Recent findings: A select number of pathogens have been reported to increase the incidence of specific cancers (directly through altering gene expression or indirectly through inducing chronic inflammation). These have been referred to as oncogenic pathogens. Conversely, a subset of pathogens has been demonstrated to preferentially cause lysis of tumor cells, leading to tumor regression and improved anti-tumor immunity. These have been termed oncolytic pathogens. However, the contribution of non-oncogenic, non-oncolytic pathogens to both tumor growth and regression is likewise being increasingly recognized.

Summary: Pathogens have both the ability to cause and cure cancer. However, the mechanisms underlying these pathogen-mediated outcomes are not fully understood. With the recent emergence of interest in the immunotherapy of cancer, it is important that future studies focus specifically on preventing the negative effects of oncogenic infections, deconstructing the positive role of oncolytic pathogens, and finally providing insight into the dual roles of non-oncolytic, non-oncogenic pathogens so that anti-pathogen immune responses can be harnessed as a transformative means to treat cancer.

Keywords: Cancer; Infection; Inflammation; Non-oncogenic; Non-oncolytic; Oncogenic; Oncolytic; Pathogen.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

The authors declare that they have no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Figures

Fig. 1
Fig. 1
Role of infections in cancer. This schematic describes the manner in which oncogenic, oncolytic, and non-oncogenic, non-oncolytic pathogens affect cancer formation and cancer regression

Similar articles

Cited by

References

    1. Jessy T. Immunity over inability: the spontaneous regression of cancer. J Nat Sci Biol Med. 2011;2(1):43–49. doi: 10.4103/0976-9668.82318. - DOI - PMC - PubMed
    1. Kaufman HL, Kohlhapp FJ, Zloza A. Oncolytic viruses: a new class of immunotherapy drugs. Nat Rev Drug Discov. 2015;14(9):642–662. doi: 10.1038/nrd4663. - DOI - PMC - PubMed
    1. Javier RT, Butel JS. The history of tumor virology. Cancer Res. 2008;68(19):7693–7706. doi: 10.1158/0008-5472.CAN-08-3301. - DOI - PMC - PubMed
    1. Ciuffo G. Innesto positivo con filtrato di verruca volgare. Giorn Ital Mal Venereol. 1907;48:12–17.
    1. Ellermann V, Bang O. Experimentelle leukamie bei huhnern. Zentralbl Bakteriol Parasitenkd Infektionskr Hyg. 1908;46:595–597.

LinkOut - more resources